We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

COP:NYSEConocoPhillips Analysis

Data as of 2026-09-06 - not real-time

$134.26

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

ConocoPhillips is priced at $134.26 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 11.6%. With RSI at 62.8 the momentum picture is approaching overbought, alongside a bearish MACD signal. Watch $119.17 as support and $137.42 as the nearer resistance level.
On valuation the read is fair — earnings multiple of 17.8 versus a 17.8 sector average, in line with the peer group. Sell-side targets cluster 8.2% above the current quote. Revenue is growing at 35.5% on a 14.4% profit margin. The 2.50% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 30.2%, a beta of -0.52 and a maximum drawdown of 22.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.

Top Market Events

ConocoPhillips NYSE:COP picked a good week to hand over the keys.ConocoPhillips NYSE:COP picked a good week to hand over the keys.ConocoPhillips COP beats production guidance with record Permian output, doubles share repurchases, and advances LNG...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 112.74
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 17.8 versus sector average of 17.8
  • Trading above the 200-day average of 112.74

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 17.8 versus sector average of 17.8
  • Analyst targets imply +8.2% versus the current price
  • Revenue growth of +35.5%

Key Metrics & Analysis

Financial Health

Revenue Growth35.50%
Profit Margin14.40%
P/E Ratio17.8
ROE14.18%
ROA7.53%
Debt/Equity35.64
P/B Ratio2.5
Op. Cash Flow$21.9B
Free Cash Flow$7.7B
Industry P/E17.8

Technical Analysis

TrendBullish
RSI62.8
Support$119.17
Resistance$137.42
MA 20$130.84
MA 50$120.17
MA 200$112.74
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$207.93
Target Price$145.33
Upside/Downside8.25%
GradeFair
TypeBlend
Dividend Yield2.50%

Risk Assessment

Beta-0.52
Volatility30.24%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.